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ABSTRACT
Various transcription factors, including C/EBP, GCN4
and members of the Fos, Jun and Myc families have
been shown to form highly specific complexes via a-
helical structures referred to as leucine zippers.
Experimental evidence has suggested that dimerization
involves the formation of hydrophobic bonds between
leucine residues in laterally aligned coiled coil
structures. However, the specificity of interaction
between leucine zipper proteins is not understood. In
this study, we show that amino acids, which are located
in positions a, e, and g are instrumental in the formation
of Fos/Jun heterodimers, presumably by establishing
intermolecular electrostatic and hydrophobic
interactions. These residues are highly conserved in
proteins of the Fos or Jun families but completely
different between Fos and Jun, suggesting that these
residues determine the specificity of interaction. This
conclusion is supported by the observation that the
substitution of amino acids in position a or g in Fos with
the corresponding Jun amino acids facilitates the
association of two Fos leucine repeats. In addition, we
show that a conserved histidine residue, located 7
amino acids (i.e., two a-helical turns) C-terminally to
the 5th leucine in Fos and Jun, is also important for
complex formation.
INTRODUCTION
A variety of transregulatory proteins are known to bind to distinct
DNA elements as dimeric protein complexes. These consist of
either protein homodimers, as is the case of the transcriptional
activators GCN4 and C/EBP (1,2) or heterodimers consisting
of two different proteins, such as Fos and Jun (for a review see
3,4) and some members of the ATF family (5). Heterodimeric
complexes between Fos and Jun [referred to as the transcription
factor AP-1; (6)] bind with high affinity to a specific DNA
sequence, the TPA-response element [TRE; 7-14].
It has been proposed that the interaction of the two proteins
is mediated by a heptad repeat of five leucines present in both
proteins, known as the 'leucine zipper' (2). This spacing of
leucine residues within a putative a-helix is conserved in various
other proteins including GCN4, C/EBP, Fos-, Jun-, Myc-, and
ATF family members (listed in Busch and Sassone-Corsi, 15).
The leucine zipper model is supported by the results of
mutagenesis experiments which showed that leucine residues are
essential for the dimerization of Fos and Jun (10, 16—21).
Moreover, we and others could demonstrate that dimer formation
is a prerequisite for specific binding to a palindromic TRE (9,
11, 16,18, 22), stimulation of AP-1 dependent transcription and
induction of morphological transformation (19). Based on
observations made with synthetic leucine zipper containing
peptides, an alternative model was proposed by O'Shea et al.
which postulates that the heptad leucine repeat is a coiled coil
(23, 24). In this model, a stable interaction is mediated by a 4 - 3
repeat of hydrophobic amino acids, and the specificity of this
interaction can be modulated by charged residues in adjacent
helical positions.
The 'scissors grip' model addresses the interaction of zipper
protein dimers with dyad-symmetric DNA recognition sequences
(25). This model predicts that the helices of the two interacting
proteins disengage beyond the leucine zipper due to the repulsion
of the positively charged surfaces in the adjacent basic DNA
binding domains. The a-helices of the two interacting proteins
are suggested to bifurcate and to form Y-like shaped structures.
The bifurcation point is thought to meet the DNA at the center
of the dyad-symmetric site, thus enabling the 'two arms of the
Y' to interact with the two half sites of the DNA recognition
sequence by tracking in opposite directions along the major
groove of the DNA. Recently, experimental evidence supporting
the 'scissors grip' model was obtained, based on the dimerization
and DNA-binding characteristics of synthetic or purified leucine
zipper containing protein fragments (26-28).
The interaction of leucine residues, however, cannot account
for the observed selectivity in dimer formation among proteins
sharing a leucine repeat structure. It seems likely that amino acids
other than leucines confer the dimerization specificity. Support
for this conclusion comes from 'domain swapping' experiments.
Substitution of the leucine zipper of Fos with the corresponding
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domain from either Jun or GCN4 enabled the resulting chimeric
protein to form homodimers, which specifically bind to the TOE
(29 — 31). Although a few cases have been reported, where
substitutions of single non-leucine residues in Jun affected its
complex forming potential with Fos (32, 33), the random
mutagenesis of amino acids in the Fos zipper did not have any
significant effect on its binding to Jun (19, 20).
In the present study, we have performed a systematic
mutational analysis of non-leucine residues in Fos and Jun and
determined their contribution to the formation of heterodimers.
Our results show that amino acids in those helical positions, which
in a three-dimensional a-helix are located close to the leucines
(i.e, positions a, e and g), are crucial for the formation of
heterodimers, presumably by establishing electrostatic or
hydrophobic interactions. Since these residues are highly
conserved among Fos and Jun family members but different
between Fos and Jun, it is likely that these amino acids determine
the specificity of interaction and thus prevent Fos-Fos homodimer
formation due to the repulsion of equally charged amino acid
side chains. In agreement with this conclusion, we find that the
dimerization of Fos zippers is facilitated when the amino acids
in position a or g are replaced with the corresponding Jun amino
acids. Moreover, we show, by swapping wild-type or mutant
leucine zippers between Fos and Jun, that the specificity of protein
complex formation via leucine repeats is not dependent on the
presence of other amino acid sequences.
METHODS
Fos zipper mutants
The parental Fos construct used in this study is E300, a C-
terminally truncated Fos hybrid gene derived from the FBJ-MuSV
and FBR-MuSV encoded oncogenes. The protein derived from
this hybrid construct is identical to c-Fos except for the lack of
64 C-terminal amino acids and 3 FBJ-MuSV-specific point
mutations (outside the leucine zipper; also described in (19). All
Fos zipper mutants are shown in Fig. 2.
Insertion of new restriction sites by site-directed mutagenesis
In order to facilitate the production of a large number of mutants,
new unique restriction sites were introduced by oligonucleotide-
directed mutagenesis, according to the gapped duplex DNA
method based on the pMa/c 5 — 8 vector system [Stanssens, Me
Keown, Friedrich, and Fritz, unpublished data; for a detailed
description see (19)]. In E300, two appropiate restriction sites
had already been inserted 5' and 3' of the zipper [Sstl at nucleotide
position 2,418 and Sphl at 2,547 as described in 29)]. The leucine
zipper region could thus be excised with Sstl and Sphl and
replaced by synthetic oligonucleotides harbouring single or
multiple amino acid changes. In addition, a Xbal site at position
2,606 was created with the following oligonucleotide (non-coding
strand of the FBR-MuSV fos gene):
(2,620) 5'-CCAGTCAAATCTAGAGAGGCCACAGACATCTC-3' (2,589)
Xba\
All changes and substitutions by synthetic oligonucleotides
were subsequently confirmed by sequence analysis. The modified
E300 inserts were then subcloned into the in vitro
transcription/translation vector pTZ18R.
Mutants FZ1-6, FZ2-5, FZ3-5, FZ3-5J, FZ4-4/1, FZ4-6,
FZ4-6J, FZ5-6, FZ6-6, and L4H
To mutate multiple amino acids in the same construct, four
overlapping oligonucleotides (82 and 47bp for the coding strand,
71 and 58 bp for the non-coding strand) were treated with T4
Polynucleotide kinase, allowed to rehybridize, digested with Sstl
and Sphl, isolated by gel electrophoresis, recovered on glass
beads (Geneclean, Dianova) and inserted into the Sstl/Sphl sites
of E300. Wherever possible, a new restriction site which did not
alter the amino acid sequence was also introduced to facilitate
the identification of mutants.
Mutants FZ1-2 and FZ3-2
In a first cloning step we inserted 4 new unique restriction sites
into the Fos zipper region without changing the amino acid
sequence (construct FZO, not listed in Fig. 2), using the procedure
described above. These were Xhol at position 2,450, AflU at
2,495, £«JRI at 2,516 and HindYR at 2,522 (35). Mutants FZ1-2
and FZ3-2 were then generated by cloning a synthetic, double-
stranded oligonucleotide into the Xhol (2,450)/£coRI (2,516) sites
or Xhol (2,450)/Hindltt(2,522) sites, respectively.
Mutants FZ44/2, FZ4-3, FZ4-2, FZ4-1, FZFZ3-3/4-2J, and
FZ4-4/3-2J
The internal AflU (2,495) site in most of the mutants described
allowed the exchange of the N-terminal or C-terminal halves of
the Fos zipper. Mutants FZ4-4/2 and FZ4-3 were generated by
replacing the C-terminal leucine zipper sequences (AflU to SphT)
of FZ4-6 and 4-4/1 with wild-type sequences present in FZO.
FZ4-2 and 4-1 were obtained by replacing the N-terminal
sequences (Sstl to AflO) with those of FZO. Constructs FZ3-3/4-2J
and 4-4/3-2J were generated by mutual exchange of the C-
terminal halves of FZ4-6J and FZ3-5J (via the AflO. site).
Mutants L2, L4, and L5
These constructs were generated by site-directed mutagenesis of
individual leucine residues in the Fos zipper and have been
described earlier (19).
Mutants 206-AA and EGGSD
For construct 206-AA, a double-stranded oligonucleotide
spanning a Sphl (2,547)/Xbal (2,606) fragment was cloned into
the corresponding restriction sites of FZO. EGGSD was generated
by cloning a double-stranded oligonucleotide with EcoRl (2,516)-
Styl (2,562) termini into the corresponding restriction sites of
206-AA (providing the new Styl site).
This construct represents E300 with a Jun leucine zipper (see
Fig. 3) and has been described in (29).
Jun zipper mutants
A full length cDNA clone of c-jun (37) served as template for
all mutagenesis experiments. In analogy to E300, two unique
restriction sites were introduced 5' and 3' to the leucine zipper
by site-directed mutagenesis, a HindHI site at nucleotide position
1,180 and an EcoRl site at position 1,311 [numbering according
to (37)] using the following oligonucleotides (non-coding strand):
(1,190) 5 '-CCGAGCGATCCGCTCAAGCTTCCTTTTCCGG-3' (1,170)
Hindm
(1,333) SMXATGAGTTGGCACCCAGAATTCACGTGGTTCATGAC-3' (1,297)
EcoRl
Mutants JZ3-4, JZ5-5, JZ4-6, and JZ3-2/1
These were obtained by cloning four overlapping oligonucleotides
encoding the respective amino acid changes (see Fig. 2 ) into
the new HindUl and EcoRl sites in c-jun, essentially as described
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for some of the Fos mutants above. Construct JZ3-2/1 contains
an additional Sstl site at position 1,244 located 5' to the two amino
acid changes in helical position 3.
Mutants JZ1-2, JZ3-2, JZ4-1, JZ4-2, and JZ7-1 (L4)
Based on construct JZ3-2/1, oligonucleotides with Sstl (1,244)
and fcoRI (1,311) termini containing the respective mutations
were inserted into the corresponding vector sites replacing the
3-2/1 mutation.
Four synthetic overlapping oligonucleotides encoding the entire
region of the c-Fos leucine zipper (aa 160-201, see Fig. 3) were
inserted into the HindTH—EcoRl sites ofc-jun as described above.
This cloning step did not regenerate the original sites since the
palindromic recognition sequences were altered in the insert. In
addition, the oligonucleotides harbored Sstl, Xhol, AJM, EcoRl,
and HindHl sites in the same positions as described for FZO. This
enabled the transfer of certain Fos zipper mutants into a Jun
background.
JFZ3-3, JFZ34, JFZ44, JFZ4-5, JFZ3-3/4-1, and JFZ4-4/3-1
JFZ3-4 and JFZ4-5 were obtained by cloning the Sstl-EcoRl
fragments of mutant FZ3-5J and the Sstl-HindYR fragment of
FZ4-6J into the corresponding sites of *-Jun. From this construct,
a 210 bp C-terminal AflQ-Sall fragment was excised in both
mutants and replaced with the corresponding fragment of *-Jun
to yield constructs JFZ3-3 and JFZ4-4. Likewise, the mutual
exchange of the same C-terminal DNA fragments between
JFZ3^ and 4-5 yielded constructs JFZ3-3/4-1 and 4-4/3-1.
In vitro reconstitution of Fos/Jun complexes
DNA constructs were linearized and transcribed in vitro as
described before (19). The RNA was then translated using rabbit
reticulocyte lysate (Promega Biotech). The translation efficiency
was checked by co-translating an aliquot of each construct in the
presence of 35S-methionine followed by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE). After electrophoresis, gels were
fixed and processed in Amplify (Amersham), dried and exposed
to Fuji RX film. Translation efficiency was determined by
scanning the autoradiographs and identical amounts of each
protein were used in reconstitution assays. All proteins were
synthesized with similar efficiencies. Reconstitution experiments
were performed as described before (19). 35S-methionine labeled
Jun was incubated with unlabeled Fos and immunprecipitated with
Fos-specific antibodies (antisera 455 or KX, the latter kindly
provided by Dr. H. Rahmsdorf). Proteins were then analyzed
by SDS-PAGE and processed as described above.
RESULTS
Mutational analysis of non-leucine residues in the Fos and
Jun leucine repeat
A helical wheel representation of the Fos and Jun leucine repeats
and the interactions predicted by the coiled-coil model are shown
in Fig. 1 (24). We first investigated whether amino acids other
than leucines may participate in Fos-Jun heterodimer formation.
Mutant proteins were generated in which parts of the leucine
repeats in Fos and Jun were replaced with synthetic
oligonucleotides via restriction sites introduced by siteKlirected
mutagenesis (see Methods for details). We systematically changed
the amino acids located at a distance of 1, 2, 3, 4, 5 or 6 residues
relative to the preceding leucine (i. e. in the helical positions e,
Figure 1. Helical wheel representation of the Fos and Jun leucine repeats according
to O'Shea et al. (24), including the conserved histidines in position d. The view
is from the N-terminus towards the C-terminus. The most N-tenninally located
amino acids in each helical position are shown in outlined fonts. Numbers refer
to the position of the corresponding amino acid relative to the preceding leucine.
Potential interactions between residues in helical positions d and d' Geucines),
a and a' (hydrophoblc), and e and g, respectively (electrostatic), are indicated
by arrows.
/ , g, a, b, and c; see Fig. 1). In a first series of mutants, all
residues in a given position in Fos (which in an ideal a-helix
are located on top of each other as shown in Fig. 1) were altered.
To preserve the a-helical conformation of the leucine repeat,
amino acids in the Fos zipper were replaced either with the
corresponding residues from Jun or with other non-leucine amino
acids that are likely to be found within a-helical domains
[according to Richardson and Richardson (34), e.g., alanine,
valine, aspartic acid, glutamic acid or lysine] in positions a and
g. A summary of all Fos mutants used in this study is shown
in Fig. 2. The leucines in position d were excluded from the
mutagenesis since their role in Fos-Jun association has already
been established (19). After in vitro transcription/translation the
mutated Fos proteins were analyzed for heterodimer formation
with Jun. As shown in Fig. 4a, alterations of 5 or 6 amino acids
in position b, c or/(lanes 6, 2 and 7) had no detectable effect,
while mutations in positions a, e or g (lanes 4, 5, and 3)
practically abolished binding (> 10% of E300, i. e., a FBJ/FBR
hybrid protein containing a wild-type leucine repeat). Two leucine
mutants which have previously been described were included in
this analysis (for details see Methods) and showed a - 6 0 %
decrease in binding as reported in (19).
We then analyzed whether amino acids in similar positions in
the leucine zipper in Jun may also be crucial for complex
formation. Positions a, b and g in Jun were replaced either with
the corresponding residues from Fos or with other a-helix-
forming amino acids (see Fig. 2). The results shown in Fig. 4b
strongly suggest that changes in positions a and g dramatically
affect binding to Fos: the substitution of 6 and 4 amino acids
in these positions decreased the association with Fos by > 95 %
and 76%, respectively (constructs JZ4-6 and JZ3-4, lanes 2 and
3), while no decrease in binding was detected when 5 amino acids
in position b were changed (construct JZ5-5, lane 4).
Substitution of individual amino acids located in the leucine
zipper
With a second series of mutants the relevance of positions a, e
and g in Fos and Jun was further investigated. To make the effects
obtained with Fos and Jun zipper mutants comparable, single and
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Figure 3. Structure of the •-Jun zipper mutants and of •-Fos, and binding to
E300 (Fos) and •-Fos, respectively. Numbeij at the top of the two panels indicate
amino acid positions in the Jun and Fos protein, respectively; the numbers below
refer to the helical position of the respective amino acid relative to the preceding
leucine (see helical wheel model in Fig. 1). The sequences below are +-Jun and
•-Fos, as indicated. Amino acids of Fos transferred into Jun, and Jun residues
transferred into Fos are double underlined. The +-Jun mutants (termed JFZ) are
identical to the parental protein shown at the top, except for the changes indicated.
* percentage of binding to in vitro translated Fos or •-Fos. Calculations were
performed as described in Fig 2 and wild-type binding normalized to 100%.
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Figure 2. Top panel: Structure of the Fos leucine zipper mutants and binding
to Jun. Numbers at the top indicate amino acid positions in the Fos protein; the
numbers below refer to the helical position of the respective amino acid relative
to the preceding leucine (see helical wheel model in Fig. 1). The wild-type Fos
(E300) sequence is shown below. The mutant sequences are identical to E300
except for the positions shown. Bottom panel: Structure of the Jun leucine zipper
mutants and binding to E300 (Fos). Numbers at the top indicate amino acid
positions in the Jun protein; the numbers below refer to the helical position of
the respective amino acid (see helical wheel model in Fig. 1). The wild-type Jun
sequence is shown below. The mutant proteins are identical to the wild-type Jun
sequence, except for the changes indicated.
Nomenclature: FZ: Fos proteins with mutations in the zipper, the first number
indicates the position of the residue(s) changed, the number following the slash
is the total number of residues changed. Constructs L2, L4, and L5 have been
published previously. JZ: Jun proteins with mutations in the zipper; numbers have
the same meaning as described for FZ mutants.
*: percentage of binding to in vitro translated Jun. Values were determined by
densitometry and normalized to 100% binding for E300. Each value represents
a mean value of at least two reconstitution experiments.
b: Amino acids substituted in FZ constructs derived from Jun.
c: Amino acids substituted in JZ constructs derived from Fos.
• Jun
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kD
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double mutations were introduced at corresponding positions
using alanine for substitutions wherever possible (Fig. 2). The
ability of the Fos mutants to form heterodimers with Jun was
analyzed in the experiment shown in Fig. 5a. The data suggest
that, apart from the known crucial role of leucine residues in
position d, amino acids in position 4 appear to be of particular
importance. The exchange of 2 amino acids in FZ4-2 (lane 5)
reduced binding to 12% (as determined by scanning the
autoradiograph; see legend to Fig. 2). Substitutions in positions
e and g (FZ1-2 and FZ3-2), which are directly adjacent, have
comparably moderate effects, reducing the binding to Jun by
about 40% relative to E300. Alterations of 3 or more amino acids
in positions a and e in Fos practically abolished binding (FZ3-3,
FZ4-3, ¥7AAI\ and FZ4^/2 in Fig. 2). In contrast, a single
30
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Figure 4. Complex formation between Fos proteins mutated in different helical
positions and wild-type Jun (panel a), and between Jun proteins mutated in
analogous positions and wild-type Fos (panel b). The structure of the mutants
and the nomenclature is described in Fig. 2. The in vitro reconstitutions and
immunoprccipitanons were carried out as described in Methods. Wild-type Jun
and Jun mutants were translated in the presence of 35S-methionine and complexed
to unlabeled Fos. Quantitation was done as explained in Fig. 2. Mutants L4 and
L2 were included for comparison.
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Figure 5. Effect of point mutations and two-amino acid changes in the putative
interaction surface of Fos and Jun. Mutated proteins were allowed to bind to
the respective wild-type counterpart, immunoprecipitated and analyzed as described
in Fig. 4. Panel a: Fos zipper mutants complexed with Jun; panel b: Jun mutants
complexed with Fos (E300). Nomenclature as in Fig. 2. Jun-FS: frame shift mutant
starting at position 299 in c-Jun. Con: 35S-labeled Jun precipitated with Fos
antiserum KX (no Fos added).
Figure 6. Complex forming potential of Fos proteins mutated in sequences C-
terminal to the leucine repeat (amino acids 194-207) with Jun. The structure
of the mutants and a quantitation of the results is shown in Fig. 2. Mutant L4
(lane 2) was included as a reference for the double mutant L4-H.
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point mutation of Lys-190 to alanine (position a) in Fos had
practically no effect on dimer formation ( Figs. 2 and 5a).
A similar set of leucine zipper mutants was also generated with
Jun. Reconstitution of the Jun mutants with E300 protein yielded
binding activities which were clearly position dependent and were
largely analogous to the results described above for Fos (compare
relative binding values in Fig. 2; reconstitutions shown in Figs.
5a and b). In analogy to construct FZ4-1, the mutation of Val-308
to alanine in JZ4-1 did not affect its binding to Fos (Fig. 5b).
The JZ4-2 mutant, on the other hand, which carries an additional
mutation (Val-315 — Ala) showed a considerable decrease in
binding (16% binding relative to Jun); its binding activity is thus
comparable to that of the corresponding Fos mutant FZ4-2 (12%
binding). Constructs JZ3-2/1, JZ3-2/2 and JZ1-2 showed
moderately reduced binding (60-70%), similar to the analogous
Fos constructs (FZ mutants). Interestingly, mutant JZ7-1
(Leu-304 — Val) showed enhanced binding (125%), unlike its
Fos counterpart L4 (Leu-186 — Ala; 45% binding).
Mutation of a conserved histidine C-terminal to the leucine
repeat affects Fos/Jun complex formation
We next extended our studies to amino acids outside the leucine
zipper. We focussed our attention particularly on a histidine
located 7 amino acids C-terminally to the 5th leucine, because
this residue is completely conserved in all proteins of the Fos
and Jun families (Fig. 2). Interestingly, His-200 turned out to
be crucial for the interaction of Fos and Jun. While L4, a mutant
of Fos where the 4th leucine is exchanged with alanine (Fig. 2)
Figure 7. Effect of Jun sequences in positions 3 and 4 in Fos. The Fos mutants
were complexed with wild-type Jun. Nomenclature as in Fig. 2, reconstitution
and quantitative evaluation as indicated in Fig. 4. Con: 33S-labeled Jun
precipitated with Fos antiserum KX (no Fos added).
showed only slightly reduced binding properties compared to
E300, the additional mutation of His-200 (construct L4H)
completely destroyed binding to Jun (Fig. 6, lanes 1—3). Another
mutant with changes adjacent to His-200 also showed reduced
binding (EGGSD; lane 5; 35% binding). Mutation of 2 adjacent
amino acids located closer to the C-terminus had no detectable
effect (206-AA; lane 4).
Exchange of amino acids between Fos and Jun leucine zippers
We next attempted to analyse whether the non-leucine residues
also confer the specific character of the Fos/Jun association. Since
it could not be excluded that sequences outside the leucine repeat
might contribute to a significant extent to the binding specificity,
we first analysed hybrid constructs (referred to as ¥-Jun and V-
Fos) in which the leucine repeat in Jun was replaced with the
zipper from Fos and vice versa. In the case of *-Jun, this was
achieved by first introducing appropiate restriction sites into the
c-jun cDNA by site-directed mutagenesis and the replacement
of the leucine zipper with a synthetic oligonucleotide (see Methods
for details). The ¥-Fos construct has previously been described
(29). As shown in Fig. 8a (lane 2), the ¥-Jun protein did not
show any significant binding to Fos, but associated efficiently
with ¥-Fos. Complex formation between ¥-Fos and ¥-Jun
occurred with similar efficiency as the association between Fos
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Figure 8. Specificity of dimerization determined by testing the dimer forming
potential of •-Jun (Fos zipper in Jun) and +-Jun mutants (substituted in positions
3 and 4 by Jun sequences). For nomenclature and quantitation see Fig. 3. Panel
a: reconstitution with Fos protein (E300); panel b: reconstitution with +-Fos (Jun
zipper in Fos) or E300 as indicated above the lanes. All Jun proteins were labeled
in the presence of 33S-methionine. Con: 33S-labeled Jun precipitated with Fos
antiserum KX (no Fos added).
and Jun (Fig. 8b, lanes 3 and 6). This shows that the binding
specificity is an integral part of the leucine zipper and is not
dependent on other sequences in the protein.
We then introduced specific mutations into the Fos zipper,
replacing amino acids in position a or g with corresponding
residues from Jun (see Fig. 2). In contrast to substitutions with
random helix-forming amino acids (FZ4-6), the presence of Jun
residues in position a enabled the mutant Fos protein (construct
FZ4-6J) to bind with even higher affinity to Jun than E300 (125%
binding; Fig. 7). Substitutions in position g had adverse effects.
Construct FZ3-5J showed strongly reduced affinity (18% binding;
Fig. 7). As seen with two other mutants (FZ3-3/4-2J and
FZ4-4/3-2J), changes in position g are dominant over those in
position a (Figs. 2 and 7).
To analyse whether amino acids in these positions may
determine the specificity of the interaction and thus prevent Fos
homodimer formation, we next transferred the respective Fos
zipper mutations into the •-Jun construct and analyzed the
encoded proteins for complex formation with E300. While the
•-Jun construct, which contains the wild-type Fos zipper did not
show any significant binding to E300, the introduction of 4 Jun
amino acids into position g in the Fos zipper of •-Jun (constructs
JFZ3^t) increased the binding to E300 to 32% (Figs. 3 and 8a).
This mutation eliminates the 4 glutamic acid residues in position
g which may exert repulsive forces in Fos homodimers. Construct
JFZ3-3, which leaves the last glutamic acid residue intact, shows
lower binding (15%).
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Figure 9. Amino acid conservation in the leucine repeats of Fos and Jun proteins.
The sequence between Glu-160 and Arg-201 in c-Fos was aligned with the
corresponding sequence in Fra-1, Fra-2 and FosB (taken from 38-40). Likewise,
amino acids between Glu-278 and Val-319 in c-Jun were aligned with the
corresponding residues in JunB and JunD (according to 6, 37, 41 -43). Amino
acids are displayed according to their topological position in the heptad repeat
(see helical wheel model in Fig. 1) from N-terminal (top) to C-terminal (bottom);
conserved amino acids among all Fos or Jun proteins are shown in outlined font.
Numbers above refer to the helical position relative to the preceding leucine.
Elimination of an additional positive charge in position a
(construct JFZ3-3/4-1), however, has a similar effect as the
substitution of the 4th glutamic acid in helical position g (compare
to JFZ3-4). This result indicates that the charged amino acids
in helical positions a and g are at least in part responsible for
the lack of Fos to form homodimers. This conclusion is supported
by the second series of constructs analyzed in this experiment.
Five Jun residues introduced into position a also increased
complex formation with Fos (16%; JFZ4-5; Figs. 3 and 8a). In
contrast, construct JFZ4-4, in which the last lysine was left
unchanged, did not show enhanced binding relative to •-Jun (6%
versus 9%). Elimination in this construct of an additional negative
charge (glutamic acid) in helical position g, however, significandy
enhanced the association with Fos (JFZ4-4/3-1; 28%).
An important role for amino acids in helical positions a and
g in the specificity of protein-protein association is also suggested
by the ability of •-Jun proteins with mutations in their Fos zipper
to form complexes with •-Fos. Mutant JFZ4-5 showed strongly
enhanced binding to •-Fos (approximately two-fold; Figs. 3 and
8b, lane 4), similar to the binding of FZ4-6J to Jun (Fig. 7, lane
4). In analogy to the reduced binding of FZ3-5J to Jun (18%;
Fig. 7, lane 3), JFZ3-4 and •-Fos also showed a weaker
interaction, although the effect was less pronounced (67%; Fig.
8b, lane 5). These data confirm the conclusion that the binding
characteristics of zipper mutants can be preserved when
transferred into a different protein 'background'.
DISCUSSION
bZip proteins constitute a class of structurally distinct
transcriptional regulators, whose hallmark is the presence of a
leucine zipper, serving as a protein dimerization interface,
adjacent to an a-helical basic region, which is instrumental in
DNA binding. The invariant spacing between both regions and
the conservation of specific residues in most, if not all bZip
proteins have led Vinson et al. (25) to propose the 'scissors grip'
model (see Introduction for details). According to this model,
two bZip proteins form homodimeric or heterodimeric
complexes via the leucine zippers, and establish specific contacts
to a dyad-symmetric DNA sequence with the basic regions of
both proteins binding to one half site of the palindromic DNA
element. The structural features of the bipartite DNA binding
site and the conformational changes upon binding to DNA have
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recently been elucidated in some detail (26—28). In addition,
these and other studies performed with purified proteins or
synthetic peptides (23, 24, 28) have provided sufficient evidence
to conclude that the interaction of bZip proteins is brought about
by the parallel, non-covalent association of laterally aligned coils.
Despite this structural information, the mechanism determining
the dimerization of either identical or non-identical protein
subunits is poorly understood and experimental evidence in this
direction is limited. A convincing model was suggested by O'Shea
et al., which postulates that two heptad repeats of hydrophobic
residues in each leucine zipper are likely to interact in a coiled
coil. The specificity of interaction would be determined by amino
acids in adjacent positions, predominantly charged residues (23,
24). In this study, we have performed a comprehensive structure-
function analysis to characterize some aspects of the Fos/Jun
complex formation. The analysis of the mutant proteins was
performed in an in vitro reconstitution assay, which has
previously been shown to allow for a quantitative analysis of
complex forming properties (19). To exclude the possibility that
mutation-related structural changes affected the results, we tested
three different polyclonal antisera with the same set of mutants
[Fos antiserum 455 and KX; Jun antiserum K31(35),
Adamkiewicz, unpublished results]. In these experiments, we
could not find any significant differences regardless of which
antiserum was chosen (data not shown).
The interaction of Fos and Jun is dependent on amino acids
in four different helical positions
Our results clearly indicate that non-leucine residues are
instrumental in the formation of heterodimers between Fos and
Jun. In Fos, amino acids in positions a, e and g are crucial, and
in Jun, at least residues in positions a and g. The importance
of position 1 in Jun, however, is suggested by the effects seen
with construct JZ1-2. A more detailed analysis of single or double
mutants within these positions revealed that changes in
corresponding positions in either Fos or Jun had similar effects
on the complex formation. Substitutions of 2 or more residues
in position a had a more pronounced effect on the binding than
those in positions e or g, resulting in a similar loss in binding
as the elimination of 2 leucines (19). In contrast, single mutations
of amino acids in positions a, e and g in Fos did not show any
noticeable reduction in binding to Jun, similar to the substitution
of some of the leucines (19).
As all the amino acids in Fos and Jun which were identified
to contribute to complex formation are located close to leucine
residues, it is likely that they form one single dimerization
surface. In agreement with the results of our structure-function
analysis, positions a and d show total conservation, positions e
and g show 67% identity (16 out of 24 residues) among the known
members of each family (see Fig. 9). In this context it is
noteworthy, that amino acids C-terminal to the 5th leucine, like
His-200 in Fos, are also well conserved and important for protein
dimerization. We therefore conclude that the leucine zipper may
comprise at least one additional helical turn. It seems unlikely,
however, that the dimerization domain extends much further since
residues located more C-terminally in Fos are rich in prolines
and presumably disrupt the or-helical configuration.
The leucine repeats in Fos and Jun are exchangeable
functional domains
In a previous study, we and others have demonstrated that, by
transferring the leucine zipper of Jun or GCN4 into Fos, the
dimerization specificity of the acceptor protein was changed to
that of the donor protein (29—31). In this study, we have extended
these analyses by replacing the leucine repeat in Jun by that of
Fos (Fig. 3). The resulting *-Jun protein was shown to bind to
*-Fos, a Fos protein containing the Jun leucine zipper. This
binding was stable under the stringent conditions of the
immunoprecipitation (RIP A buffer), similar to the wild-type Fos-
Jun complex. *-Jun was, however, unable to form dimers with
wild-type Fos (Fig. 8b, lanes 3 and 6; Fig. 8a, lane 2). It could
be argued that the low increase in the amount of ^-Jun visible
in Fig. 8a was due to residual dimer formation with Fos.
However, this increase was also obtained in the absence of Fos
protein (Fig. 8b, lane 2) and therefore most likely represents
immunological cross-reactions. This is conceivable, since the 42
Fos residues in ¥-Jun are also present in the antigen used to
generate the polyclonal 455 and KX antisera. Based on these data,
we conclude that (i) the zipper region in each protein can function
as an independent unit and (ii) can confer binding specificity to
a heterologous protein.
Determinants of preferential dimer formation
Based on the findings discussed above, we have attempted to
localize residues in Fos and Jun that are crucial in determining
the binding specificity. The net charges of the Fos and Jun leucine
zippers are equal but of opposite polarity (24). It could thus be
speculated that electrostatic interactions play an important role
in the specificity of dimerization by favoring the formation of
heterodimers and weakening or preventing the interaction of
homodimers. This notion is supported by our observation that
the incorporation of 5 Jun amino acids into Fos in position g (with
a change in the net charge from - 4 to + 2; construct FZ3-5J)
or 6 residues in position e (with a net charge changing from +2
to - 1 ; construct FZ1-6) results in practically no binding to Jun.
This conclusion is substantiated by the fact that these amino acids
(helical positions e and g) are relatively well conserved among
members of the same family (especially in Fos proteins) but are
not conserved across the Fos and Jun family. In agreement with
this interpretation, a similar alteration in position g of *-Jun (with
the net charge changing from - 3 to + 1; construct JFZ3^4) leads
to an increased association with Fos. Furthermore, a single amino
acid change affecting the last glutamic acid residue in helical
position g has a clear positive effect on complex formation with
Fos (compare JFZ3^ and JFZ3-3 or JFZ44 and JFZ4-4/3-1).
Thus, substitutions in position g and probably in position e in
Fos do not only affect the stability of the Fos-Jun complex but
in addition change the protein's binding specificity.
Different conclusions can be drawn from the results obtained
with proteins where amino acids were exchanged in position a
between Fos and Jun. When introduced into a Fos zipper, the
Jun amino acids seem to facilitate both the Fos/Jun as well as
the Fos/^-Jun association. Our current view is that, as suggested
by O'Shea et al., the hydrophobic Jun repeat in position a confers
a higher degree of stability due to an increased number of
potential hydrophobic interactions. This notion is supported by
the binding behavior of construct JFZ4-5 in which the nearly
perfect hydrophobic repeat of Jun residues allows dimer formation
with Fos, despite the putative repulsion effect of some charged
residues in both zippers (in positions e and g). In Fos, the
corresponding repeat is markedly less hydrophobic and contains
two lysines. While the hydrophobic character of the leucine side
chains may support the formation of stable Fos-Jun complexes
(24), their positive charge is likely to contribute to the prevention
of a Fos-Fos homodimer formation. The latter hypothesis is in
agreement with the results described in Figs. 3 and 8 which show
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that the elimination of a single positive charge (lysine) in helical
position a can lead to a clearly enhanced association of Fos
zippers (compare JFZ4-5 and JFZ4-4 or JFZ3-3 and JFZ3-3/4-1).
Compatibility with the coiled coil model
Two of the features predicted by the coiled coil model of O'Shea
et al. (23, 24) were of particular relevance for our study: (i) A
repeat of hydrophobic non-leucine residues builds the 4-3 heptadic
repeat together with the heptad leucine repeat, similar to the
parallel a-helical coiled coils of fibrous proteins, (ii) Charged
amino acids in the laterally aligned sequences effect the specificity
of interactions and prevent 'promiscuous' dimer formation. As
discussed above, the experimental data obtained in this study can
indeed be best explained by this concept. Our observations are
also in agreement with the observations of Smeal et al. (32), who
analyzed the effect of substituting single or multiple amino acids
in the leucine zipper of Jun.
Based on the available evidence we come to the following
conclusions: (i) the preferential heterodimer formation between
Fos and Jun is due to the synergistic effect of both interhelical
hydrophobic interactions and mutual electrostatic attraction, (ii)
The relatively weak formation of Jun homodimers could be
explained by the repulsion of positively charged arginines and
lysines (net charge of + 5 in positions e and g) counteracting
the hydrophobic interactions of the 4-3 repeat, (iii) Fos-Fos
homodimer formation is completely prevented due to the additive
effect of both the lower number of hydrophobic interactions and
the repulsion of lysines in position 4 on the one hand, and the
repulsion of 6 glutamic acid residues in the two lateral positions
e and g.
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